Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Snowflake entered the pending Q2 FY2027 report with strong operating momentum: Q1 product revenue grew 34%, remaining performance obligations grew 38%, and management raised FY2027 product-revenue and non-GAAP operating-margin guidance. AI adoption is becoming material to engagement, with more than 13,600 accounts using AI capabilities. Nevertheless, the August 28 closing quote of $328.00 already reflects substantial execution expectations. A Hold balances accelerating growth, expanding large-customer adoption, and improving non-GAAP operating leverage against consumption-model volatility, competition, continued GAAP losses, and the risk of sharp multiple compression after a guidance miss.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets48 analysts · as of 18 Aug 2026
Low · most bearish analyst$110.00
Mean target$308.93
High · most bullish analyst$500.00
Street targets sit below today's price; our intrinsic value sits above it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$110.0019%

Product revenue falls below the Q2 guidance floor, net revenue retention drops below 120%, or AI adoption does not translate into durable consumption. A guidance reduction or stalled operating leverage would challenge the premium expectations embedded in the current share price.

Base CaseCentral scenario
$308.9356%
Matches the consensus mean

Snowflake executes near the $1.415 billion-$1.420 billion Q2 product-revenue range and approximately delivers its $5.84 billion FY2027 product-revenue plan while non-GAAP operating margin progresses toward 13.5%. The base target is an internal scenario judgment referenced to the issuer-reported $328.00 market price.

Bull CaseUpside scenario
$500.0025%

Product revenue exceeds the Q2 guidance ceiling, net revenue retention remains near or above 126%, AI workloads accelerate core-platform consumption, and Snowflake raises its FY2027 outlook again. Sustained growth above the current plan with improving operating leverage supports a premium outcome.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Q1 FY2027 product revenue increased 34% year over year to $1.334 billion, and management raised full-year product-revenue guidance to $5.84 billion.
  • Remaining performance obligations reached $9.21 billion, up 38% year over year, while customers contributing more than $1 million in trailing-12-month product revenue increased 29% to 779.
  • More than 13,600 accounts were using Snowflake AI capabilities, while accounts using Snowflake Intelligence more than doubled sequentially and Cortex Code was used across more than 7,100 accounts.
Sign in / Sign up to read more
Key Investment Risks
  • Snowflake recognizes product revenue from customer consumption, making quarterly growth sensitive to workload timing, optimization, holidays, and customers' budget decisions.
  • Q1 FY2027 remained GAAP-loss-making despite positive non-GAAP operating income, and stock-based compensation-related charges were substantial.
  • The $328.00 August 28 share price leaves limited room for operational disappointment ahead of the September 2 earnings report.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.